Pasadena, CA, United States of America

Scott C Virgil

This inventor holds 15 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: California Institute of Technology, University of California, 1200 Pharma LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott C Virgil. Retrieved from https://idiyas.com/inventor/scott-c-virgil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 93.3

 

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Scott C. Virgil: Innovator in Heterocyclic Compounds

Introduction

Scott C. Virgil is a notable inventor based in Pasadena, California, who has made significant contributions to the field of chemical innovations. With a robust portfolio of 13 patents, Virgil's work primarily focuses on the development of heterocyclic compounds containing quaternary centers, highlighting his expertise and creativity in chemical research.

Latest Patents

Among his latest patents, Virgil introduces advancements in quaternary heteroatom-containing compounds. His innovations provide methods for preparing novel heterocyclic compounds with specific structural features. Notably, his patented method involves treating a compound of formula (I) with a transition metal catalyst, conducted under alkylation conditions that consider valence and stability, ultimately leading to the production of compounds as outlined in formula (II).

Career Highlights

Virgil's impressive career includes affiliations with prestigious institutions such as the California Institute of Technology and the University of California. His experiences at these renowned organizations have fostered an environment where his inventive spirit could flourish, enabling him to focus on groundbreaking research and development.

Collaborations

Throughout his journey, Scott C. Virgil has had the opportunity to collaborate with esteemed colleagues, including Brian M. Stoltz and David E. White. These partnerships have enriched his research endeavors and led to innovative breakthroughs in the field of heterocyclic compounds.

Conclusion

Overall, Scott C. Virgil stands out as a prominent inventor whose work in developing quaternary heteroatom-containing compounds continues to push the boundaries of chemical science. With a strong foundation in both academic and collaborative settings, his contributions will undoubtedly have a lasting impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…